6:06am ET
Investing
Amgen’s (AMGN) Troubled Quarter
Amgen (AMGN) actually rallied a bit after hours yesterday. But, revenue growth was hard to come by. Amgen reported net income of $1.02 billion, or 90 cents per share, for the quarter…
Companies
/Healthcare
Boston Scientific Corp
$48.30
â–² $1.46 (+3.12%) today
Markets closed · 6:39am ET
BSX Coverage
Page 187:41am ET
Investing
Stent Blockage Kills Boston Scientific (BSX)
A large drop in the sale of drug coated stents knocked Boston Scientific’s (BSX) quarter way down. The company’s second-quarter profit, excluding charges, was $271 million, or 18 cents per share, compared…
Douglas A. McIntyre 7:16am ET
Investing
Better Medicine For Boston Scientific (BSX)
Boston Scienfitic (BSX) has a deal to "settle all pending federal lawsuits against the company alleging harm from faulty defibrillators and pacemakers for $195 million," according to The Wall Street Journal. It…
Douglas A. McIntyre 5:05pm ET
Investing
Top Earnings Next Week Part 2 (July 19-20, 2007)
THURSDAYAdvanced Micro Devices (NYSDAQ:AMD)Ameritrade (NASDAQ:AMTD)Bank of America (NYSE:BAC)Bank of New York (NYSE:BK)Cemex (NYSE:CX/ADR)Continental Airlines (NYSE:CAL)Cypress Semi (NYSE:CY)Dow Jones (NYSE:DJ)Fifth Third Bancorp (NASDAQ:FITB)First Data (NYSE:FDC)Gilead Sciences (NASDAQ:GILD)Google (NASDAQ:GOOG)Harley-Davidson (NYSE:HOG)Honeywelll (NYSE:HON)Illinois Tool Works (NYSE:ITW)International…
3:12am ET
Investing
Media Digest 7/5/2007 Reuters, WSJ, NYTimes, FT, Barron’s
According to Reuters, Australia Australian fund manager Caledonia said it would vote against Chicago Merch’s (CME) proposal to buy CBOT (CBOT) The fund own over 6% off the exchange. Reuters writes that…
12:16pm ET
Health and Healthcare
Mixed Short Interest in Drug & Medical Stocks (June 2007)
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but…
4:36pm ET
Health and Healthcare
Short Selling Up in Drug & Medical Stocks
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is…